Wealth Enhancement Advisory Services, LLC Biotechnology

Wealth Enhancement Advisory Services, LLC

$49 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VERV Verve Therapeutics, Inc.	$315M	$83,000 0.0% of portfolio	18,215	Q1 2025 New
HRTX Heron Therapeutics, Inc.	$255M	$78,000 0.0% of portfolio	35,616	Q1 2025 Added 1.37%
VIR Vir Biotechnology, Inc.	$769M	$77,000 0.0% of portfolio	11,962	Q1 2025 New
ALT Altimmune, Inc.	$238M	$72,000 0.0% of portfolio	14,564	Q1 2025 Reduced 6.57%
ALDX Aldeyra Therapeutics, Inc.	$142M	$62,000 0.0% of portfolio	10,910	Q1 2025 New
EDIT Editas Medicine, Inc.	$107M	$52,000 0.0% of portfolio	45,017	Q1 2025 Added 144.45%
LEXX Lexaria Bioscience Corp.	$8.39M	$52,000 0.0% of portfolio	30,959	Q1 2025 Added 7.22%
SANA Sana Biotechnology, Inc.	$329M	$50,000 0.0% of portfolio	30,264	Q1 2025 New
SGMO Sangamo Therapeutics, Inc	$122M	$45,000 0.0% of portfolio	69,250	Q1 2025 Reduced 43.45%
GALT Galectin Therapeutics Inc	$79.6M	$44,000 0.0% of portfolio	36,141	Q1 2025 Reduced 29.84%
MRSN Mersana Therapeutics, Inc.	$36.9M	$44,000 0.0% of portfolio	130,700	Q1 2025 New
NKTR Nektar Therapeutics	$124M	$41,000 0.0% of portfolio	60,371	Q1 2025 New
IPSC Century Therapeutics, Inc.	$31.8M	$40,000 0.0% of portfolio	85,083	Q1 2025 Added 8.18%
RLAY Relay Therapeutics, Inc.	$352M	$40,000 0.0% of portfolio	15,472	Q1 2025 New
ERAS Erasca, Inc.	$169M	$38,000 0.0% of portfolio	28,139	Q1 2025 New
TNYA Tenaya Therapeutics, Inc.	$19.4M	$33,000 0.0% of portfolio	58,547	Q1 2025 New
IVA Inventiva S.A.	$162M	$31,000 0.0% of portfolio	10,715	Q1 2025 New
LXRX Lexicon Pharmaceuticals, Inc.	$121M	$31,000 0.0% of portfolio	69,207	Q1 2025 New
NKTX Nkarta, Inc.	$108M	$31,000 0.0% of portfolio	17,365	Q1 2025 New
ORMP Oramed Pharmaceuticals Inc.	$88.9M	$29,000 0.0% of portfolio	13,799	Q4 2024 Added 22.12%
ALLO Allogene Therapeutics, Inc.	$229M	$28,000 0.0% of portfolio	19,260	Q1 2025 New
VTYX Ventyx Biosciences, Inc.	$66.7M	$28,000 0.0% of portfolio	24,483	Q1 2025 New
CHRS Coherus Bio Sciences, Inc.	$84.7M	$26,000 0.0% of portfolio	33,249	Q1 2025 Added 7.79%
ALXO Alx Oncology Holdings Inc	$24M	$25,000 0.0% of portfolio	40,551	Q1 2025 Added 3.63%
FATE Fate Therapeutics Inc	$133M	$23,000 0.0% of portfolio	29,909	Q1 2025 New
MAIA Maia Biotechnology, Inc.	$20.5M	$22,000 0.0% of portfolio	14,800	Q2 2024 Reduced 7.5%
ADCT Adc Therapeutics Sa	$95.5M	$21,000 0.0% of portfolio	14,990	Q1 2025 New
ALEC Alector, Inc.	$91.6M	$16,000 0.0% of portfolio	13,678	Q1 2025 Added 23.89%
CRBU Caribou Biosciences, Inc.	$51.1M	$16,000 0.0% of portfolio	17,951	Q1 2025 New
IGMS Igm Biosciences, Inc.	$42.3M	$13,000 0.0% of portfolio	11,584	Q1 2025 New
RAPT Rapt Therapeutics, Inc.	$24.3M	$13,000 0.0% of portfolio	11,020	Q1 2025 New
STRO Sutro Biopharma, Inc.	$42.3M	$11,000 0.0% of portfolio	17,199	Q1 2025 New
OCGN Ocugen, Inc.	$149M	$10,000 0.0% of portfolio	14,837	Q1 2025 Added 1.76%
APLT Applied Therapeutics Inc.	$16.3M	$7,000 0.0% of portfolio	14,775	Q1 2025 New
XFOR X4 Pharmaceuticals, Inc	$13.7M	$7,000 0.0% of portfolio	33,327	Q1 2025 Added 10.11%
LYEL Lyell Immunopharma, Inc.	$114M	$6,000 0.0% of portfolio	12,596	Q1 2025 New
ADAP Adaptimmune Therapeutics PLC	$45.7M	$5,000 0.0% of portfolio	26,816	Q4 2024 Added 147.93%
CGTX Cognition Therapeutics Inc	$8.4M	$4,000 0.0% of portfolio	10,000	Q4 2024 New
VXRT Vaxart, Inc.	$43M	$4,000 0.0% of portfolio	10,000	Q1 2025 Reduced 2.02%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.